DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma

被引：0
|
作者：
Thomas Fleischer
Hege Edvardsen
Jovana Jovanovic
Nizar Touleimat
Anne-Lise Børresen-Dale
Jörg Tost
Vessela N Kristensen
机构：
[1] Oslo University Hospital Radiumhospitalet,Department of Genetics, Institute for Cancer Research
[2] University of Oslo,The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine
[3] University of Oslo,Institute for Clinical Epidemiology and Molecular Biology (EpiGen), Faculty of Medicine
[4] Centre National de Génotypage,Laboratory for Epigenetics
[5] CEA - Institut de Génomigue,undefined
来源：
Epigenetics & Chromatin | / 6卷 / Suppl 1期
关键词：
Breast Cancer; Invasive Carcinoma; Mammographic Density; Gene Body; Inhibit Gene Expression;
D O I：
10.1186/1756-8935-6-S1-P18
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The role of TACC3 in the progression from ductal carcinoma in situ to invasive breast cancer
    Campo, Loredana
    Mathew, Maya
    Breuer, Eun-Kyoung
    Small, William
    CANCER RESEARCH, 2017, 77
  • [22] Genes regulating the progression of human ductal carcinoma in situ to invasive breast cancer
    Lee, Sangjun
    Stewart, Sheila
    Luo, Jingqin
    Medina, Daniel
    Allred, D. Craig
    CANCER RESEARCH, 2011, 71
  • [23] Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer
    Mange, Alain
    Lacombe, Jerome
    Bascoul-Mollevi, Caroline
    Jarlier, Marta
    Lamy, Pierre-Jean
    Rouanet, Philippe
    Maudelonde, Thierry
    Solassol, Jerome
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1992 - 2000
  • [24] Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
    Doebar, S. C.
    Krol, N. M.
    van Marion, R.
    Brouwer, R. W. W.
    van Ijcken, W. F. J.
    Martens, J. M.
    Dinjens, W. N. M.
    van Deurzen, C. H. M.
    VIRCHOWS ARCHIV, 2019, 474 (02) : 247 - 251
  • [25] Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
    S. C. Doebar
    N. M. Krol
    R. van Marion
    R. W. W. Brouwer
    W. F. J. van Ijcken
    J. M. Martens
    W. N. M. Dinjens
    C. H. M. van Deurzen
    Virchows Archiv, 2019, 474 : 247 - 251
  • [26] Integrative Analysis of DNA Methylation and Gene Expression Patterns in Tissues from Hepatocellular Carcinoma Patients
    Barefoot, Megan E.
    Chen, Yifan
    Varghese, Rency S.
    Zhou, Yuan
    Ressom, Habtom W.
    2019 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2019, : 267 - 274
  • [27] Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis
    Thomas Fleischer
    Arnoldo Frigessi
    Kevin C Johnson
    Hege Edvardsen
    Nizar Touleimat
    Jovana Klajic
    Margit LH Riis
    Vilde D Haakensen
    Fredrik Wärnberg
    Bjørn Naume
    Åslaug Helland
    Anne-Lise Børresen-Dale
    Jörg Tost
    Brock C Christensen
    Vessela N Kristensen
    Genome Biology, 15
  • [28] Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast
    Asiaf, Asia
    Ahmad, Shiekh Tanveer
    Malik, Ajaz Ahmad
    Aziz, Shiekh Aejaz
    Rasool, Zubaida
    Masood, Akbar
    Zargar, Mohammad Afzal
    TUMOR BIOLOGY, 2015, 36 (08) : 6485 - 6496
  • [29] Ductal carcinoma in situ of the breast and gene expression markers for prediction of invasive recurrence
    McKean, H. A.
    Reynolds, C.
    Hoskin, T. L.
    Suman, V. J.
    Grant, C. S.
    Erlander, M. G.
    Ma, X.
    Ingle, J.
    Goetz, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] The Effect of Smoking on Progression from Ductal Carcinoma In Situ to Invasive Ductal Breast Carcinoma: A Retrospective Study
    Takada, Koji
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2022, 42 (01) : 311 - 320
12345